Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

• Hoofdauteurs: Vladimír Blaha MUDr, CSc (Auteur), Roman Margoczy MUDr (Auteur), Ivo Petrov MD (Auteur), Arman Postadzhiyan MD, PhD, FESC, FACC (Auteur), Katarína Rašlová MUDr, CSc (Auteur), Hana Rosolová MUDr, DrSc (Auteur), Ian Bridges MSc (Auteur), Nafeesa N. Dhalwani PhD (Auteur), Marie Zachlederova PhD (Auteur), Kausik K. Ray FESC (Auteur)
• Formaat: Boek
• Gepubliceerd in: SAGE Publishing, 2023-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Purpose: We examined clinical characteristics and low-density lipoprotein cholesterol (LDL-C) lowering in patients initiating evolocumab in real-world practice in a Central and Eastern European (CEE) cohort from the pan-European HEYMANS study. Methods: Patients from Bulgaria, Czech Republic, and Slo...